April 26, 2024 | |
Name of listed company: Chugai Pharmaceutical Co., Ltd. | |
Code number: | 4519 (Prime Market of Tokyo Stock Exchange) |
Head office: | 1-1,Nihonbashi-Muromachi2-Chome,Chuo-ku, Tokyo |
President & CEO: | Osamu Okuda |
Inquiries to: | Kae Miyata |
Head of Corporate Communications Dept. | |
Tel: +81-(0)3-3273-0554 |
Notice of Completion of Disposal of Treasury Shares as Restricted
Stock Compensation Plan
TOKYO, April 26, 2024--Chugai Pharmaceutical Co., Ltd.announced that disposal of treasury shares was completed today, as we announced in the press release "Notice of Disposal of Treasury Shares as Restricted Stock Compensation Plan" on March 28, 2024. The result of treasury shares is as follows.
1. Overview of Disposal
(1) | Disposal date | April 26, 2024 | ||
(2) | Class and number of disposed shares | 100,200 shares of Common stock of the Company | ||
(3) | Disposal price | ¥5,927 per share | ||
(4) | Total value of disposed shares | ¥593,885,400 | ||
(5) | Allottees and number thereof; | Directors | 3 | 38,800 shares |
number of disposed shares | Vice presidents | 11 | 22,000 shares | |
Employees | 105 | 35,500 shares | ||
Director of subsidiaries | 4 | 1,200 shares | ||
Employees of subsidiaries 9 | 2,700 shares |
###
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Chugai Pharmaceutical Co. Ltd. published this content on 26 April 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 26 April 2024 14:36:31 UTC.